Do you have the same question? Follow this Question
Nov 14, 2024 - 01:38 PM
We’ve provided several answers to questions related to Rexulti (Brexpiprazole) , see some other helpful Q&A related to this product.
Question: What is the DrugBank ID for this medication?
Answer: The DrugBank ID for this medication is DB09128. DrugBank provides detailed drug data, which is useful for researchers and healthcare professionals in understanding drug properties and interactions.
Question: What is the starting dose for pediatric patients with schizophrenia?
Answer: The starting dose for pediatric patients with schizophrenia (13-17 years old) is 0.5 mg/day. Starting with a lower dose in pediatric patients helps ensure safe and effective treatment while monitoring for any adverse effects.
Question: What is the max dose for adults with major depressive disorder?
Answer: The max dose for adults with major depressive disorder is 3 mg/day. Ensuring the dose does not exceed this maximum helps prevent potential adverse effects while maintaining efficacy.
Question: What is the legal status of this medication?
Answer: The legal status of this medication is Rx-Only, meaning it requires a prescription from a healthcare provider. Prescription-only status ensures that the medication is used under medical supervision, which is important for safety and effectiveness.
Question: What is the formula of the medication?
Answer: The formula for the medication is C25H27N3O2S. Understanding the chemical formula is important for healthcare professionals to verify the composition and ensure it aligns with treatment needs.
